TINI PAOLO

Contacts

0763/711229 - 338/1204173

Teaching activities

Completion accademic year: 2024/2025

Course year: 2 First cycle degree (DM 270) IMAGING AND RADIOTHERAPY TECHNIQUES A.Y. 2023/2024
Course year: 2 First cycle degree (DM 270) AUDIOPROTHESIC TECHNIQUES A.Y. 2023/2024
Course year: 5 Full cicle (6 years) MEDICINE AND SURGERY A.Y. 2020/2021
Course year: 5 Full cicle (6 years) MEDICINE AND SURGERY A.Y. 2020/2021
Course year: 1 First cycle degree (DM 270) IMAGING AND RADIOTHERAPY TECHNIQUES A.Y. 2024/2025

Completion accademic year: 2023/2024

Course year: 2 First cycle degree (DM 270) AUDIOPROTHESIC TECHNIQUES A.Y. 2022/2023
Course year: 2 First cycle degree (DM 270) IMAGING AND RADIOTHERAPY TECHNIQUES A.Y. 2022/2023
Course year: 5 Full cicle (6 years) MEDICINE AND SURGERY A.Y. 2019/2020

Research

Ultime pubblicazioni:

  • Tini, P., Yavoroska, M., Mazzei, M.A., Miracco, C., Pirtoli, L., Tomaciello, M., et al. (2023). Low expression of Ki-67/MIB-1 labeling index in IDH wild type glioblastoma predicts prolonged survival independently by MGMT methylation status. JOURNAL OF NEURO-ONCOLOGY, 1-6 [10.1007/s11060-023-04342-2]. - view more
  • Minniti, G., Tini, P., Giraffa, M., Capone, L., Raza, G., Russo, I., et al. (2023). Feasibility of clinical target volume reduction for glioblastoma treated with standard chemoradiation based on patterns of failure analysis. RADIOTHERAPY AND ONCOLOGY, 181, 1-7 [10.1016/j.radonc.2022.11.024]. - view more
  • Raza, G.H., Capone, L., Tini, P., Giraffa, M., Gentile, P., Minniti, G. (2022). Single-isocenter multiple-target stereotactic radiosurgery for multiple brain metastases: dosimetric evaluation of two automated treatment planning systems. RADIATION ONCOLOGY, 17(1), 1-11 [10.1186/s13014-022-02086-3]. - view more
  • Vagnoni, L., Aburas, S., Giraffa, M., Russo, I., Chiarella, V., Paolini, S., et al. (2022). Radiation therapy for atypical and anaplastic meningiomas: an overview of current results and controversial issues. NEUROSURGICAL REVIEW, 45(5), 3019-3033 [10.1007/s10143-022-01806-3]. - view more
  • Nardone, V., Giannicola, R., Bianco, G., Giannarelli, D., Tini, P., Pastina, P., et al. (2021). Inflammatory markers and procalcitonin predict the outcome of metastatic non-small-cell-lung-cancer patients receiving PD-1/PD-L1 Immune-Checkpoint Blockade. FRONTIERS IN ONCOLOGY, 11, 1-9 [10.3389/fonc.2021.684110]. - view more